FENNEC PHARMACEUTICALS (FENC) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
FENNEC PHARMACEUTICALS insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 8 sold $12.6M of FENC stock on the open market.
Get emailed when insiders cluster-buy stocks like FENC
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
FENC insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $1.5M | 6 |
| Q2 2026 | — | 0 | $291K | 4 |
| Q1 2026 | — | 0 | $243K | 3 |
| Q4 2025 | — | 0 | $10.6M | 11 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 FENNEC PHARMACEUTICALS INC. insiders reported open-market purchases totaling $0, while 8 insiders reported sales totaling $12.6M. 16 of 24 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 16SEC | Marco Maria BrugheraDirector | Sell Plan | 15,545 | $10.29 | $160K | +4.1% | — |
| Sep 1SEC | Rosty RaykovFormer Director | Sell Plan | 10,000124,411 held (−7%) | $12.11 | $121K | -11.6% | — |
| Aug 31SEC | Pierre Sargis SayadChief Medical Officer | Sell | 12,0009,519 held (−56%) | $12.18 | $146K | -12.1% | — |
| Aug 28SEC | Robert AndradeCFO | Sell Plan | 75,000217,675 held (−26%) | $11.78 | $884K | -9.1% | — |
| Aug 4SEC | Rosty RaykovFormer Director | Sell Plan | 10,000131,633 held (−7%) | $9.58 | $96K | +11.8% | — |
| Jul 2SEC | Rosty RaykovFormer Director | Sell Plan | 9,599138,855 held (−6%) | $10.41 | $100K | +2.9% | — |
| Jun 2SEC | Rosty RaykovDirector | Sell Plan | 9,747130,079 held (−7%) | $9.62 | $94K | +11.3% | — |
| May 12SEC | Chris A RallisDirector | Sell Plan | 8,34663,077 held (−12%) | $7.04 | $59K | +52.1% | — |
| May 1SEC | Rosty RaykovDirector | Sell Plan | 10,781121,451 held (−8%) | $6.47 | $70K | +65.5% | — |
| Apr 2SEC | Rosty RaykovDirector | Sell Plan | 10,946113,856 held (−9%) | $6.31 | $69K | +69.7% | — |
| Mar 3SEC | Rosty RaykovDirector | Sell Plan | 10,079103,996 held (−9%) | $8.36 | $84K | +28.1% | — |
| Feb 2SEC | Rosty RaykovDirector | Sell Plan | 10,34998,477 held (−10%) | $7.76 | $80K | +38.0% | — |
| Jan 5SEC | Rosty RaykovDirector | Sell Plan | 10,31288,020 held (−10%) | $7.60 | $78K | +40.9% | — |
| Dec 29SEC | Southpoint Capital Advisors Lp10% Owner | Sell | 1,000,0002,744,741 held (−27%) | $7.50 | $7.5M | +42.8% | — |
| Dec 5SEC | Rosty RaykovDirector | Sell Plan | 10,00077,526 held (−11%) | $7.54 | $75K | +42.0% | — |
| Nov 20SEC | Southpoint Capital Advisors Llc10% Owner | Sell | 19,3413,744,741 held (−1%) | $8.79 | $170K | +21.8% | — |
| Nov 17SEC | Southpoint Gp, Llc10% Owner | Sell | 160,1003,850,000 held (−4%) | $8.00 | $1.3M | +33.9% | — |
| Nov 17SEC | Southpoint Gp, Llc10% Owner | Sell | 85,9183,764,082 held (−2%) | $8.79 | $755K | +21.8% | — |
| Nov 6SEC | Rosty RaykovDirector | Sell Plan | 10,00082,318 held (−11%) | $8.10 | $81K | +32.2% | — |
| Oct 14SEC | Chris A RallisDirector | Sell Plan | 1,77557,079 held (−3%) | $9.24 | $16K | +15.9% | — |
| Oct 9SEC | Southpoint Capital Advisors Llc10% Owner | Sell | 26,9004,050,314 held (−1%) | $9.59 | $258K | +11.7% | — |
| Oct 9SEC | Southpoint Capital Advisors Llc10% Owner | Sell | 20,6094,010,100 held (−1%) | $9.35 | $193K | +14.5% | — |
| Oct 9SEC | Southpoint Capital Advisors Llc10% Owner | Sell | 19,6054,030,709 held (−0%) | $9.47 | $186K | +13.1% | — |
| Oct 6SEC | Rosty RaykovDirector | Sell Plan | 10,00082,501 held (−11%) | $9.78 | $98K | +9.5% | — |
Insiders at FENNEC PHARMACEUTICALS INC.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Southpoint Capital Advisors Lp10% Owner | — | $7.5M | Dec 29, 2025 | — |
| Southpoint Gp, Llc10% Owner | — | $2.0M | Nov 17, 2025 | — |
| Rosty RaykovFormer Director | — | $1.0M | Sep 1, 2026 | — |
| Robert AndradeCFO | — | $884K | Aug 28, 2026 | — |
| Southpoint Capital Advisors Llc10% Owner | — | $806K | Nov 20, 2025 | — |
| Marco Maria BrugheraDirector | — | $160K | Sep 16, 2026 | — |
| Pierre Sargis SayadChief Medical Officer | — | $146K | Aug 31, 2026 | — |
| Chris A RallisDirector | — | $75K | May 12, 2026 | — |
FENC stock: common questions
Are FENNEC PHARMACEUTICALS INC. insiders buying FENC stock?
In the past 12 months, 0 insiders reported open-market purchases of FENC worth $0.
Are FENNEC PHARMACEUTICALS INC. insiders selling FENC stock?
8 insiders reported sales worth $12.6M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is FENC's 52-week range?
Over the past year FENC has traded between $5.77 and $12.78. It last closed at $10.71 on Oct 9, 2026.